Here we report that there are no differences in the permeability into the CNS after experimental inflammation and there are no significant changes in brain water content or in permeability. Interestingly, we show that the TG is more than 30 times more permeable than the CNS at normal conditions and thereby supporting the idea that anti-migraine drugs may reach much higher and clinically relevant levels within the TG than they do in the CNS.